Validating the MoCA for screening 3 83 mocatest.org (no date). Available at: https://www.mocatest.org/ (Accessed: 31 December 2019). Nasreddine, Z. S. et al. (2005) ‘The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment’, Journal of the American Geriatrics Society, 53(4), pp. 695–699. doi: 10.1111/j.1532-5415.2005.53221.x. Neary, D. et al. (1994) ‘Clinical and neuropathological criteria for frontotemporal dementia’, Journal of Neurology, Neurosurgery and Psychiatry, 57(4), pp. 416–418. doi: 10.1136/jnnp.57.4.416. Nederlandse Vereniging voor Klinische Geriatrie (2014) Richtlijn ‘Diagnostiek en medicamenteuze behandeling van dementie’. Utrecht: CBO. Available at: https://www.nvvp.net/stream/richtlijndiagnostiek-en-behandeling-van-dementie-2014. O’Caoimh, R., Timmons, S. and Molloy, D. W. (2016) ‘Screening for mild cognitive impairment: Comparison of “MCI Specific” screening instruments’, Journal of Alzheimer’s Disease. IOS Press, 51(2), pp. 619–629. doi: 10.3233/JAD-150881. Prince, M. and Comas-Herrera, A. (2016) ‘World Alzheimer Report 2016’. Available at: www.alz.co.uk. Pugh, E. A. et al. (2018) ‘Effects of Normative Adjustments to the Montreal Cognitive Assessment’, American Journal of Geriatric Psychiatry, 26(12), pp. 1258–1267. doi: 10.1016/j.jagp.2018.09.009. Rascovsky, K. et al. (2011) ‘Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia’, Brain, 134(9), pp. 2456–2477. doi: 10.1093/brain/awr179. Reisberg, B. et al. (1982) ‘The global deterioration scale for assessment of primary degenerative dementia’, American Journal of Psychiatry, 139(9), pp. 1136–1139. doi: 10.1176/ajp.139.9.1136. Román, G. C. et al. (1993) ‘Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.’, Neurology. Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology, 43(2), pp. 250–60. doi: 10.1212/WNL.43.2.250. Rossetti, H. C. et al. (2011) ‘Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample’, Neurology, 77(13), pp. 1272–1275. doi: 10.1212/WNL.0b013e318230208a. Schouws, S. N. T. M. et al. (2012) ‘Cognitive decline in elderly bipolar disorder patients: A follow-up study’, Bipolar Disorders. doi: 10.1111/bdi.12000. Thissen, A. J. A. M. et al. (2010) ‘Bruikbaarheid en validiteit van de Nederlandse versie van de Montreal Cognitive Assessment (MoCA-D) bij het diagnosticeren van Mild Cognitive Impairment’, Tijdschrift voor Gerontologie en Geriatrie, 41(6), pp. 231–240. doi: 10.1007/s12439-010-0218-0. Volksgezondheidenzorg.info (2019) dementie aantal nieuwe gevallen naar leeftijd. Available at: https:// www.volksgezondheidenzorg.info/onderwerp/dementie/cijfers-context/huidige-situatie#!nodeaantal-nieuwe-gevallen-naar-leeftijd (Accessed: 8 August 2019). Waldron-Perrine, B. and Axelrod, B. N. (2012) ‘Determining an appropriate cutting score for indication of impairment on the Montreal Cognitive Assessment’, International Journal of Geriatric Psychiatry, 27(11), pp. 1189–1194. doi: 10.1002/gps.3768. Winblad, B. et al. (2004) ‘Mild cognitive impairment - Beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment’, in Journal of Internal Medicine, pp. 240–246. doi: 10.1111/j.1365-2796.2004.01380.x. Yesavage, J. A. and Sheikh, J. I. (1986) ‘Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version.’, Clinical Gerontologist, 5(1–2), pp. 165–173. doi: 10.1300/ J018v05n01_09.
RkJQdWJsaXNoZXIy MTk4NDMw